Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women

Women develop cardiovascular disease (CVD) approximately 7 –10 years later than men, but progress with similar risk after menopause. Recent studies suggest that hormone replacement therapy (HRT) is cardioprotective when initiated early after menopause, but the mechanisms involved are still unclear.

Source: Thrombosis Research - October 25, 2019 Category: Hematology Authors: Ida Gregersen, Else H øibraaten, Kirsten B. Holven, Lene Løvdahl, Thor Ueland, Marie-Christine Mowinckel, Tuva Børresdatter Dahl, Pål Aukrust, Bente Halvorsen, Per Morten Sandset Tags: Full Length Article Source Type: research